Poly(ethylene glycol) methacrylate hydrolyzable microspheres for transient vascular embolization
Source abstract
Abstract
Poly(ethylene glycol) methacrylate (PEGMA) hydrolyzable microspheres intended for biomedical applications were readily prepared from poly(lactide-co-glycolide) (PLGA)-poly(ethylene glycol) (PEG)-PLGA crosslinker and PEGMA as a monomer using a suspension polymerization process. Additional co-monomers, methacrylic acid and 2-methylene-1,3-dioxepane (MDO), were incorporated into the initial formulation to improve the properties of the microspheres. All synthesized microspheres were spherical in shape, calibrated in the 300-500 μm range, swelled in phosphate-buffered saline (PBS) and easily injectable through a microcatheter. Hydrolytic degradation experiments performed in PBS at 37 °C showed that all of the formulations tested were totally degraded in less than 2 days. The resulting degradation products were a mixture of low-molecular-weight compounds (PEG, lactic and glycolic acids) and water-soluble polymethacrylate chains having molecular weights below the threshold for renal filtration of 50 kg mol(-1) for the microspheres containing MDO. Both the microspheres and the degradation products were determined to exhibit minimal cytotoxicity against L929 fibroblasts. Additionally, in vivo implantation in a subcutaneous rabbit model supported the in vitro results of a rapid degradation rate of microspheres and provided only a mild and transient inflammatory reaction comparable to that of the control group.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Intracranial Aneurysms: Treatment and Complications · Electrospun Nanofibers in Biomedical Applications · Vascular Malformations Diagnosis and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (43)
Show source-provided references
1. Polyvinyl alcohol sponge for embolotherapy: particle size and morphology
2. Polyvinyl alcohol particle size and suspension characteristics
3. The size of gelatin sponge particles: differences with preparation method10.1007/s00270-006-0059-y ↗
4. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer10.1158/1078-0432.CCR-05-2225 ↗
5. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics10.1016/j.jhep.2006.10.020 ↗
6. Transcatheter occlusion of abdominal tumors10.1148/120.3.539 ↗
7. Gelatin sponge in therapeutic neuroradiology: a subject review10.1148/radiology.141.1.7027309 ↗
8. Transcatheter gelfoam embolization in abdominal, retroperitoneal, and pelvic hemorrhage10.1148/radiology.136.2.6967615 ↗
9. A new porcine sponge material for temporary embolization: an experimental short-term pilot study in swine10.1007/s00270-004-0299-7 ↗
10. Gelatine sponge particles: handling characteristics for endovascular use10.1053/j.tvir.2008.03.002 ↗
11. Magnetic resonance angiography of uterine artery: changes with embolization using gelatin sponge particles alone for fibroids10.1007/s00270-006-0196-3 ↗
12. Comparison of long-term effects between intra-arterially delivered ethanol and gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma10.3748/wjg.v10.i6.825 ↗
13. Repeated intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in inoperable metastatic hepatic cancer
14. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases10.1016/j.gassur.2005.08.004 ↗
15. Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma10.1007/s00535-012-0537-8 ↗
16. A preclinical study of the safety and efficacy of Occlusin 500 Artificial Embolization Device in sheep10.1007/s00270-011-0218-7 ↗
17. Elasticity and viscoelasticity of embolization microspheres10.1016/j.jmbbm.2011.08.001 ↗
18. Late degradation tissue response to poly (L-lactid) bone plates and screws10.1016/0142-9612(95)91092-D ↗
19. Fate of water-soluble polymers administered via different routes10.1002/jps.2600840316 ↗
20. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture10.1021/ar900035f ↗
21. Synthesis of poly-∈-caprolactone via a free radical mechanism. Free radical ring-opening polymerization of 2-methylene-1,3-dioxepane10.1002/pol.1982.170201101 ↗
22. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(α-hydroxy acid) diacrylate macromers10.1021/ma00056a005 ↗
23. Chemistry, chances and limitations of the radical ring-opening polymerization of cyclic ketene acetals for the synthesis of degradable polyesters10.1039/c0py00040j ↗
24. Hydrogels in biology and medicine: from molecular principles to bionanotechnology10.1002/adma.200501612 ↗
25. Release behaviour of high molecular weight solutes from poly(ethylene glycol)-based degradable networks10.1021/ma9915024 ↗
26. In situ forming degradable networks and their application in tissue engineering and drug delivery10.1016/S0168-3659(01)00500-4 ↗
27. End-group effects on the properties of PEG-co-PGA hydrogels10.1016/j.actbio.2009.02.030 ↗
28. Hydrolytic degradation of poly(D, L-lactide-co-glycolide 50/50)-di-acrylate network as studied by liquid chromatography-mass spectrometry10.1016/j.polymdegradstab.2011.05.022 ↗
29. Biodegradable three-dimensional networks of poly(dimethylamino ethyl methacrylate). Synthesis, characterization and in vitro studies of structural degradation and cytotoxicity10.1016/S0142-9612(99)00223-9 ↗
30. The influence of polymer topology on pharmacokinetics: differences between cyclic and linear PEGylated poly(acrylic acid) comb polymers10.1016/j.jconrel.2009.05.021 ↗
31. Novel amphiphilic, biodegradable, biocompatible, cross-linkable copolymers: synthesis, characterization and drug delivery applications10.1039/c2py20364b ↗
32. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats10.1002/jbm.820211106 ↗
33. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice10.1002/jps.2600830432 ↗
34. Dependence of pharmacokinetics and biodistribution on polymer architecture: effect of cyclic versus linear polymers10.1021/ja900062u ↗
35. Characterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymers10.1016/S0005-2736(03)00137-8 ↗
36. Hemocompatibility and cytocompatibility of styrenesulfonate-grafted PDMS-polyurethane-HEMA hydrogel10.1016/j.colsurfb.2008.12.020 ↗
37. Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis10.1016/S0046-8177(88)80204-1 ↗
38. Histologic long-term follow-up after embolization with polyvinyl alcohol particles
39. Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas10.1097/00000478-200302000-00004 ↗
40. Recanalization and particle exclusion after embolization10.1016/j.fertnstert.2007.12.015 ↗
41. Cellular and molecular dynamics in the foreign body reaction10.1089/ten.2006.12.1955 ↗
42. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model10.3348/kjr.2007.8.5.418 ↗
43. Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model10.1016/j.jvir.2013.05.058 ↗